$ SOL 3.39 OVERSOLD!!!! This solar stock could run 200%

New Post Public Reply Private Reply Replies (0) Message Board
AAAAMHIM HDOGTX #16278

$ SOL 3.39 OVERSOLD!!!! This solar stock could run 200% in 2 months. READ. New HUGE contract with the UK announced Thursday. Huge contract with Japan announced weeks ago. Huge contract with Korea. Last month I told you guys that gold was oversold and alerted ANV at 3.15 stating that it would run the hardest when gold picks up, since then ANV has run above $5 I then alerted you guys to the marajuana stock industry and told you that the stock that would have the highest gain would be EAPH, since then it has run from .002 to .017 NEARLY 1000% in days. I love oversold industries and finding the most Undervalued stocks in those OVERSOLD industries.  I brought you ANV and EAPH now I am bringing you $SOL. The solar industry has been CRUSHED recently with the downturn in the market. $SOL has the GREATEST POTENTIAL to make the highest percentage gain in the solar industry. LOOK BELOW. Don't miss out. This is as EASY as it gets.



"But it looks like ReneSola (SOL) has still got more potential for appreciation. The stock has not rallied as much as the solar panel stocks such as Trina Solar (TSL), Jinko Solar (JKS) etc. The reason is that the company still gets a lot of revenue from the sale of polysilicon and wafers. The upstream segment has not seen the same price increase as solar panels in 2013, despite operating at near capacity. I think that prices of the upstream segment will start to increase as well and this should benefit ReneSola more than others.


Why ReneSola is Still a Good Bet


i) Upstream Segment should see a Price Increase


ReneSola is one of the lowest cost producers of polysilicon and solar wafers in the industry. The company has managed to substantially reduce its polysilicon cost over time and has reached a low 20 dollar range. The company is building a new 10,000 polysilicon plant which will further reduce its poly costs. There are only a few companies left in the polysilicon business, as the solar downturn has been brutal for high cost firms. Even the lowest cost poly producers such as GCL Poly are making losses. This situation is unsustainable and I expect the prices to increase, as capacity expansion has halted in the upstream segment. Some price increases in wafers have already happened and there is even a possibility that polysilicon may see a supply shortage in 2014. This will be bullish for ReneSola as it is the only top 10 Chinese solar panel supplier with an in-house polysilicon plant.


ii) Stock Price has Underperformed in recent times


I had earlier said in 2013 that it was a good time to buy Chinese solar stocks which were heavily underperforming the USA solar stocks. It turned out to be a good call as Chinese solar stocks have given fatter returns than the US ones. In fact Canadian Solar (CSIQ) has turned out to be the best performing stock in 2012. Note ReneSola, Jinko Solar and Canadian Solar were the best performing stocks in 2012. This year ReneSola has not done as well as the other two, despite showing improving fundamentals and sharp growth in shipments.


iii) Marketshare Gains


ReneSola has sharply increased its global footprint and marketshare in 2013. The company did not even play in the solar panel segment four years ago and now is one of the biggest solar panel shippers in the world. ReneSola is also the 2nd biggest supplier of solar wafers after GCL Poly having overtaken LDK Solar .


The fastest-growing module supplier of the first half of the year was ReneSola, another leading Chinese company. Compared to the first half of last year, the company's merchant shipments more than tripled in the first six months of 2013."ReneSola is sold out for 2013 and is already preselling its 2014 production," Jin noted.


Source - IHS


iv) 2014 could be Another Good Year for Solar Panels


ReneSola has become a complete solar panel company having successfully diversified into selling solar panels, inverters, mounting systems etc. It is being expected by market research agencies that 2014 will be another strong growth year for the solar industry with estimates of solar demand ranging between 40 to 50 GW. With solar companies not expanding capacity aggressively, further solar panel price increases are expected. This should benefit ReneSola which has become a major solar panel player. The company has also been more aggressive in expanding marketshare, so expect a higher than industry growth in revenues for ReneSola. The polysilicon plant should be completed and should be operating at full capacity with low costs. This will give good returns if polysilicon prices start to increase in 2014.



Valuation


"ReneSola's valuation remains far lower than the top valued solar companies such as Sunpower and Canadian Solar. I think that ReneSola will see its multiple expand to reach at least those of the top solar companies. The company's P/B is just ~1.3x which should go up substantially as the company starts making profits. I had earlier given a price target of at least $8, when the company was trading at $2. I think that the target should be revised to at least $10, given the relative valuations of other solar stocks are much higher at the current moment of time."


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 3

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
PhoenixAI and Cloudera's Strategic Partnership Shifts Data Landscape

Updated Category News Views 8

Time to Embrace Change: PhoenixAI Teams with Cloudera Mention the word 'partnership' in the tech space, and it's often as common as a cup of joe at dawn—but this one truly shakes things up. We're talking about PhoenixAI hitching its wagon to Cloudera's startup circus, a merging of fire and steel in AI-driven database management. With PhoenixAI strutting its stuff on the...

Continue Reading
Aviator Nation Teams with NFL for 2026 Collection Launch

Updated Category News Views 6

In a move blending sports with a dash of retro flair, Aviator Nation's dropping its first NFL-licensed collection. They’re looking to serve up a blend of vintage vibes and team spirit. Aviator Nation's New Venture Launching their collection on September 24th, 2026, Aviator Nation takes a dive deeper into sports licensing, after scoring a touchdown (literally!) with an...

Continue Reading
Spotlight on AI-Powered Smart Homes for 2027

Updated Category News Views 6

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 4

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 6

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
NORD Honors Innovators Shaping Rare Disease Treatment

Updated Category News Views 8

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Continue Reading
AMD CEO, Global Leaders Converge At IMPERIA Summit

Updated Category News Views 4

A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 4

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 5

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie's TEPKINLY® Shakes Up Follicular Lymphoma Treatment

Updated Category News Views 10

TEPKINLY®'s Game-Changing Approval Your run-of-the-mill trading day just took a wild turn with AbbVie (NYSE: ABBV) flexing some serious muscle in the oncology space. Their biotech brainchild, TEPKINLY® together with lenalidomide and rituximab (R2), snagged approval from the European Commission to tackle relapsed or refractory follicular lymphoma (FL). This ain't no...

Continue Reading
Bittensor Faces Decline: Analyzing Recent Market Trends

Updated Category News Views 64

Bittensor's Recent Price Movements Bittensor's cryptocurrency, known by its ticker TAO/USD, has faced a notable decline of 6.45% in the last 24 hours, bringing its current price down to $510.45. This drop is part of a broader downward trend that has seen the price decrease by 3.0% over the past week, from $526.14 to its present value. Understanding the Market Dynamics To...

Continue Reading
Tenable's Strategic Move with Apex Security Acquisition to Boost Cyber Defense

Updated Category News Views 353

Empowering Cybersecurity Through Strategic Acquisitions Tenable Holdings, Inc., a leader in exposure management, has recently announced its intention to acquire Apex Security, a cutting-edge company dedicated to securing the increasing vulnerabilities associated with artificial intelligence. This strategic move is primarily aimed at enhancing Tenable's capability to...

Continue Reading
AUGA Group Highlights Resilience Amid Restructuring Measures

Updated Category News Views 199

AUGA Group's Interim Financial Results Reflect Strategic Adjustments AUGA Group, RAB, recently reported its consolidated interim unaudited results for a six-month period. Despite undergoing crucial restructuring phases, the Group successfully reduced costs and improved EBITDA to EUR 6.60 million. Financial Overview for the First Half of 2025 As of September 30, 2025, AUGA...

Continue Reading
Leslies Earnings on the Horizon: Brace for Impact

Updated Category News Views 156

Leslies (NASDAQ: LESL) is about to drop its quarterly earnings on February 17, 2026, and traders are bracing for impact. With estimates landing at an earnings per share (EPS) of $-4.43, the stage is set for volatility. It's a classic 'sell the news' scenario hanging over investors' heads like a dark cloud. The last quarter? A disaster—missed by $1.13, and shares took a...

Continue Reading